Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05757947
Other study ID # Super-SVG
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 22, 2022
Est. completion date December 22, 2025

Study information

Verified date February 2024
Source Meshalkin Research Institute of Pathology of Circulation
Contact Dmitry Khvan, Ph.D.
Phone +79069090505
Email dmhvan@mail.ru
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Authors hypothesize that "no-touch" saphenous vein as I graft is superior over conventional "no-touch" saphenous vein as free graft in the incidence of graft patency.


Description:

A multicenter single blind prospective randomized superiority study is conducted. Our hypothesis is that there is difference in the incidence of "no-touch" saphenous vein graft patency using it as the conventional free graft (group C) and I graft (group I) for myocardial revascularization more than 28%. If there is truly difference between groups, then total 106 patients for both groups are required to be 90% sure that the upper limit of a one-sided 95% confidence interval would reveal a difference in favour of the "no-touch" saphenous vein I graft of 28%. The blinding process is applied to a patient, who is informed about received harvesting method of saphenous vein, but don't know the type of the graft cofiguration. The study was approved by Institutional Review Board. Depending on a type of the procedure, the patients are divided into two groups: conventional free graft (group C) 53 patients and I graft (group I) 53 patients. Randomization is conducted befor operation by using accidental sampling.


Recruitment information / eligibility

Status Recruiting
Enrollment 106
Est. completion date December 22, 2025
Est. primary completion date April 1, 2025
Accepts healthy volunteers No
Gender All
Age group 25 Years to 70 Years
Eligibility Inclusion Criteria: - Patients with coronary artery disease requiring three-vessel myocardial revascularization - Patient consent to the study Exclusion Criteria: - The diameter of the target arteries for conduits of the internal mammary arteries is less than 1 mm - Hemodynamically significant atherosclerosis of the subclavian arteries in the first segment - Stenosis of the right coronary artery less than 90% - Concomitant pathology requiring additional simultaneous surgical correction - Lack of IMA - COPD with FEV1 <60% - BMI >35 - Prior heart surgery - Oncological diseases with a life expectancy of less than 5 years - ACS - CKD stage 4 and higher - The diameter of the SVG is less than 2 mm or its varicose expansion is more than 6 mm - CLTI IIb and more - Atherosclerosis of the brachiocephalic artery more than 50%

Study Design


Intervention

Procedure:
?oronary bypass surgery according to the I-graft method
Revascularization of the right coronary artery basin will be performed using "no-touch" SVG and the formation of an anastomosis of the stump of the right internal mammary artery and end-to-end saphenous vein graft.
?oronary bypass surgery by the method of free conduit
Revascularization of the right coronary artery basin will be performed using "no-touch" SVG and anastomosis of the saphenous vein graft to aorta.

Locations

Country Name City State
Russian Federation NMCR named after academician E.N. Meshalkin of the Ministry of Health of rhe Russian Novosibirsk Novosibirsk Region

Sponsors (1)

Lead Sponsor Collaborator
Meshalkin Research Institute of Pathology of Circulation

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patency of "no-touch" saphenous vein graft Assessment of the patency of coronary shunts 12 months after surgery
Secondary Recurrence of angina pectoris Estimated percentage of participants with symptomatic angina at 6 and 12 months after surgery 6 and 12 months after after surgery
Secondary MACE Estimated percentage of participants with major adverse cardiac events at 6 and 12 months post-surgery 6 and 12 months after after surgery
Secondary Complications of the conduit fence site Estimated percentage of participants with wound complications, development of wound infection, postoperative neurological complications at the sampling site at 6 and 12 months after surgery 6 and 12 months after after surgery
Secondary Survival rate Estimated percentage of participants who died at 6 and 12 months after surgery 6 and 12 months after after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A